1. Mohammadi, M.R., A.H. Omidi and H. Sabati, 2022. Current trends and new methods of detection of SARS-CoV-2 infection. Cell. Mol. Biomed. Rep., 2: 138-150.
   CrossRef  |  Direct Link  |  
2. Mohammadi, M.R. and H. Sabati, 2022. When successive viral mutations prevent definitive treatment of COVID-19. Cell. Mol. Biomed. Rep., 2: 98-108.
   CrossRef  |  Direct Link  |  
3. Bayat, M., Y. Asemani, M.R. Mohammadi, M. Sanaei, M. Namvarpour and R. Eftekhari, 2021. An overview of some potential immunotherapeutic options against COVID-19. Int. Immunopharmacol. Vol. 95. 10.1016/j.intimp.2021.107516.
   CrossRef  |  Direct Link  |  
4. Mosawi, S.H., Z. Zarghona, A. Dalimi, P. Jokelainen and A.H. Safa et al., 2019. Particularly neglected in countries with other challenges: high Toxoplasma gondii seroprevalence in pregnant women in Kabul, Afghanistan, while a low proportion know about the parasite. PLoS ONE, Vol. 14, 10.1371/journal.pone.0223585.
   CrossRef  |  Direct Link  |